Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis

Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis have?

Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis has 76 citations in the OpenAlex counts ScholarIQ stores.

When was Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis published?

Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis has 2023 year in the ScholarIQ index.

What is the open-access status of Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis?

Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis has gold oa status in the ScholarIQ index.

What is the DOI of Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis?

The DOI for Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis is on the source record.

What is the PMID of Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis?

The PMID for Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis is on the source record.

What is the OpenAlex record for Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis?

The OpenAlex for Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis is on the source record.